Ledger.Open graph →
SEC Form D · filed December 4, 2017

Innovate Biopharmaceuticals Inc

Offering
$2.0M
Sold
$1.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
RALEIGH, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Jay P. Madan · Raleigh, NCExec · Director · PromoterSandeep Laumas · Raleigh, NCExec · DirectorChris Prior · Raleigh, NCExecScott Zeilinger · New York, NYExec · DirectorJohn Bykowski · Hayward, CAExec · Director · PromoterKevin Cavenaugh · Portland, ORExec · DirectorLorne Thomas · Odessa, FLExec · Director · PromoterChris Prior · Raleigh, NCExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗